It's interesting that they did <i>not</i> just undo the inherited disease. I assumed that, especially with Sickle Cell where we have a good understanding of how it works, they would go into Chromosome 11 and put it back how it "should" be with CRISPR. But instead they apply a workaround, ensuring continued fetal haemoglobin production.<p>The article does not mention whether that's because putting Chromosome 11 back with CRISPR is harder, or whether for some reason that wouldn't fix the problem.